The features of infectious diseases departments and anti-infective practices in France and Turkey: A cross-sectional study

The aim of this study was to assess the infectious diseases (ID) wards of tertiary hospitals in France and Turkey for technical capacity, infection control, characteristics of patients, infections, infecting organisms, and therapeutic approaches. This cross-sectional study was carried out on a single day on one of the weekdays of June 17-21, 2013. Overall, 36 ID departments from Turkey (n=21) and France (n=15) were involved. On the study day, 273 patients were hospitalized in Turkish and 324 patients were followed in French ID departments. The numbers of patients and beds in the hospitals, and presence of an intensive care unit (ICU) room in the ID ward was not different in both France and Turkey. Bed occupancy in the ID ward, single rooms, and negative pressure rooms were significantly higher in France. The presence of a laboratory inside the ID ward was more common in Turkish ID wards. The configuration of infection control committees, and their qualifications and surveillance types were quite similar in both countries. Although differences existed based on epidemiology, the distribution of infections were uniform on both sides. In Turkey, anti-Gram-positive agents, carbapenems, and tigecycline, and in France, cephalosporins, penicillins, aminoglycosides, and metronidazole were more frequently preferred. Enteric Gram-negatives and hepatitis B and C were more frequent in Turkey, while human immunodeficiency virus (HIV) and streptococci were more common in France (p<0.05 for all significances). Various differences and similarities existed in France and Turkey in the ID wards. However, the current scene is that ID are managed with high standards in both countries. © 2014 Springer-Verlag.

Yazar Erdem H.
Stahl J.P.
Inan A.
Kilic S.
Akova M.
Rioux C.
Pierre I.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/8091
Tek Biçim Adres 10.1007/s10096-014-2116-9
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı European Journal of Clinical Microbiology and Infectious Diseases
Dergi Cilt Bilgisi 33
Dergi Sayısı 9
Sayfalar 1591 - 1599
Yayın Yılı 2014
Eser Adı
[dc.title]
The features of infectious diseases departments and anti-infective practices in France and Turkey: A cross-sectional study
Yazar
[dc.contributor.author]
Erdem H.
Yazar
[dc.contributor.author]
Stahl J.P.
Yazar
[dc.contributor.author]
Inan A.
Yazar
[dc.contributor.author]
Kilic S.
Yazar
[dc.contributor.author]
Akova M.
Yazar
[dc.contributor.author]
Rioux C.
Yazar
[dc.contributor.author]
Pierre I.
Yayın Yılı
[dc.date.issued]
2014
Yayıncı
[dc.publisher]
Springer Verlag
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
The aim of this study was to assess the infectious diseases (ID) wards of tertiary hospitals in France and Turkey for technical capacity, infection control, characteristics of patients, infections, infecting organisms, and therapeutic approaches. This cross-sectional study was carried out on a single day on one of the weekdays of June 17-21, 2013. Overall, 36 ID departments from Turkey (n=21) and France (n=15) were involved. On the study day, 273 patients were hospitalized in Turkish and 324 patients were followed in French ID departments. The numbers of patients and beds in the hospitals, and presence of an intensive care unit (ICU) room in the ID ward was not different in both France and Turkey. Bed occupancy in the ID ward, single rooms, and negative pressure rooms were significantly higher in France. The presence of a laboratory inside the ID ward was more common in Turkish ID wards. The configuration of infection control committees, and their qualifications and surveillance types were quite similar in both countries. Although differences existed based on epidemiology, the distribution of infections were uniform on both sides. In Turkey, anti-Gram-positive agents, carbapenems, and tigecycline, and in France, cephalosporins, penicillins, aminoglycosides, and metronidazole were more frequently preferred. Enteric Gram-negatives and hepatitis B and C were more frequent in Turkey, while human immunodeficiency virus (HIV) and streptococci were more common in France (p<0.05 for all significances). Various differences and similarities existed in France and Turkey in the ID wards. However, the current scene is that ID are managed with high standards in both countries. © 2014 Springer-Verlag.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
0934-9723
İlk Sayfa Sayısı
[dc.identifier.startpage]
1591
Son Sayfa Sayısı
[dc.identifier.endpage]
1599
Dergi Adı
[dc.relation.journal]
European Journal of Clinical Microbiology and Infectious Diseases
Dergi Sayısı
[dc.identifier.issue]
9
Dergi Cilt Bilgisi
[dc.identifier.volume]
33
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.1007/s10096-014-2116-9
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/8091
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
12
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
06 Şubat 2024 19:20
Google Kontrol
Tıklayınız
France Turkey patients single presence departments infections control differences common infection hospitals countries Turkish existed similar frequently metronidazole aminoglycosides preferred penicillins cephalosporins uniform distribution carbapenems agents anti-Gram-positive Although epidemiology tigecycline Enteric similarities Springer-Verlag standards managed
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms